Fibrillogenic amyloid β peptide 42 (Aβ42) is a known activator of NLRP3 inflammasome in migroglial cells [50] and it is involved in the pathogenesis of Alzheimer's disease [51]. Here, NLRP3 is linked to early-onset autosomal dominant Alzheimer disease.